4px6 | pdb_00004px6
From Proteopedia
SYK catalytic domain in complex with a potent pyridopyrimidinone inhibitor
| ||||||||||||
Structural highlights
Publication Abstract from PubMedWe describe two series of Syk inhibitors which potently abrogate Syk kinase function in enzymatic assays, cellular assays and in primary cells in the presence of blood. Introduction of a 7-aminoindole substituent led to derivatives with good kinase selectivity and little or no hERG channel inhibition (3b, 10c). Syk inhibitors with high potency in presence of blood.,Thoma G, Blanz J, Buhlmayer P, Druckes P, Kittelmann M, Smith AB, van Eis M, Vangrevelinghe E, Zerwes HG, Che JJ, He X, Jin Y, Lee CC, Michellys PY, Uno T, Liu H Bioorg Med Chem Lett. 2014 Apr 3. pii: S0960-894X(14)00302-3. doi:, 10.1016/j.bmcl.2014.03.075. PMID:24726806[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
| ||||||||||||||||||||
This page was last modified 06:55, 21 May 2014.